Zhongchao Inc. Launches Breast Cancer Follow-up Visit and Health Management Patient Guide Program on Breast Cancer Awareness Day

Rhea-AI Summary

Zhongchao Inc. launches a WeChat mini program to provide comprehensive health management and follow-up guidance for breast cancer patients.

Positive

• The launch of the WeChat mini program aims to support breast cancer patients in their medical journey and improve their overall quality of life.
• Consistent follow-up visits can promote early detection of potential disease recurrence and complications, leading to better survival rates.
• The Guide offers 15 essential follow-up checkpoints to elevate patient awareness in health management.
• It provides guidance on specific issues faced by patients who have undergone treatments such as endocrine therapy and radiation.
• The Guide will be periodically updated to ensure it remains a trusted and up-to-date resource for patients.

Negative

• None.

SHANGHAI, Oct. 23, 2023 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services for patients with cancer and other major diseases, today announced that its Zhongxin platform  launched a WeChat mini program of Breast Cancer Follow-up Visit and Health Management Patient Guide (the "Guide") on Breast Cancer Awareness Day. The Guide aims to provide comprehensive reference for breast cancer patients and support their health management and disease recovery through every stage of their medical journey.

Breast cancer is the leading malignancy diagnosed among women. The 2015 statistics from the American Cancer Society indicate that among female patients diagnosed with malignant tumors, nearly one-third are breast cancer. However, the advance in multidisciplinary treatments, the introduction of innovative medications, and the standardization of therapeutic approaches have contributed to a notable increase in the  five-year survival rates for breast cancer patients transitioning breast cancer patient care approach into a chronic disease management phase.

Consistent follow-up visits in chronic diseases management of breast cancer can promote early detection of signs of potential disease recurrence, metastasis, secondary tumors, complications related to treatment, and associated diseases. Standardized guidance could promote recovery throughout medical journey. Zhongchao believes that a standardized guidance during follow-up visits should take a holistic approach to health management, emphasizing side effects and health issues that may arise at different stages during breast cancer treatment. With this understanding, Zhongxin designed the patient-centric Guide, which is available on Zhongchao's WeChat mini program "Zhongxin." The Guide details 15 essential follow-up checkpoints structured around the timeline of breast cancer post-treatment, offering clarity on the importance and rationale behind each to elevate patient awareness in health management. Additionally, it provides guidance on specific issues faced by patients who have undergone treatments such as endocrine therapy and radiation, addressing areas like cardiac health, lipid levels, bone health, and pulmonary health concerns.

Zhongchao believes that the Guide will promote patients' adherence, subsequently improving their survival terms and overall quality of life. As techniques in breast cancer follow-up and health management continue to evolve, the Guide will be updated periodically, ensuring it remains a trusted and up-to-date resource for patients.

About Zhongchao Inc.

Zhongchao Inc. is an offshore holding company incorporated in the Cayman Islands. It consolidates the financial results of a variable interest entity, Zhongchao Medical Technology (Shanghai) Limited, and its subsidiaries (the "PRC operating entities") through a series of contractual arrangements. Zhongchao Inc. is a platform-based internet technology company offering services to patients with oncology and other major diseases. The PRC operating entities provide online healthcare information, professional training and educational services to healthcare professionals under their "MDMOOC" platform (www.mdmooc.org), offer patient management services in the professional field of tumor and rare diseases through Zhongxin, offer internet healthcare services through Zhixun Internet Hospital, and pharmaceutical services through Xinjiang Medical and operate an online information platform, Sunshine Health Forums, to general public. More information about the Company can be found at its investor relations website at http://izcmd.com.

Safe Harbor Statement

This press release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. When the Company uses words such as "may," "will," "intend," "should," "believe," "expect," "anticipate," "project," "estimate" or similar expressions that do not relate solely to historical matters, it is making forward-looking statements. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause the actual results to differ materially from the Company's expectations discussed in the forward-looking statements. These statements are subject to uncertainties and risks including, but not limited to, the following: the Company's goals and strategies; the Company's future business development; product and service demand and acceptance; changes in technology; economic conditions; the growth of the professional training and educational services market in China and the other international markets the Company plans to serve; reputation and brand; the impact of competition and pricing; government regulations; fluctuations in general economic and business conditions in China and the international markets the Company plans to serve and assumptions underlying or related to any of the foregoing and other risks contained in reports filed by the Company with the SEC, the length and severity of the recent coronavirus outbreak, including its impacts across our business and operations.  For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Additional factors are discussed in the Company's filings with the SEC, which are available for review at www.sec.gov. The Company undertakes no obligation to publicly revise these forward–looking statements to reflect events or circumstances that arise after the date hereof.

For more information, please contact:

At the Company: Pei Xu, CFO
Email: xupei@mdmooc.org
Phone: +86 13901629242

Investor Relations: Sherry Zheng  
Weitian Group LLC
Email: shunyu.zheng@weitian-ir.com
Phone: +1 718-213-7386

View original content:https://www.prnewswire.com/news-releases/zhongchao-inc-launches-breast-cancer-follow-up-visit-and-health-management-patient-guide-program-on-breast-cancer-awareness-day-301964002.html

SOURCE Zhongchao Inc.

FAQ

What is Zhongchao Inc. launching?

Zhongchao Inc. is launching a WeChat mini program of Breast Cancer Follow-up Visit and Health Management Patient Guide.

What is the purpose of the Guide?

The Guide aims to provide comprehensive reference and support for breast cancer patients in their health management and disease recovery.

Why are consistent follow-up visits important?

Consistent follow-up visits can promote early detection of signs of potential disease recurrence, metastasis, complications, and associated diseases.

What does the Guide offer?

The Guide offers 15 essential follow-up checkpoints, guidance on specific issues faced by patients, and clarity on the importance and rationale behind each checkpoint.

Will the Guide be updated?

Yes, the Guide will be periodically updated to ensure it remains a trusted and up-to-date resource for patients.